- Home
- IMNN vs GWAV Comparison
IMNN vs GWAV Comparison
Compare IMNN & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- GWAV
- Stock Information
- Founded
- IMNN 1982
- GWAV 2002
- Country
- IMNN United States
- GWAV United States
- Employees
- IMNN N/A
- GWAV N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- GWAV Packaged Foods
- Sector
- IMNN Health Care
- GWAV Consumer Staples
- Exchange
- IMNN Nasdaq
- GWAV Nasdaq
- Market Cap
- IMNN 12.1M
- GWAV 12.8M
- IPO Year
- IMNN 1985
- GWAV N/A
- Fundamental
- Price
- IMNN $6.53
- GWAV $0.08
- Analyst Decision
- IMNN Buy
- GWAV
- Analyst Count
- IMNN 2
- GWAV 0
- Target Price
- IMNN $182.61
- GWAV N/A
- AVG Volume (30 Days)
- IMNN 244.8K
- GWAV 4.8M
- Earning Date
- IMNN 08-05-2025
- GWAV 08-29-2025
- Dividend Yield
- IMNN N/A
- GWAV N/A
- EPS Growth
- IMNN N/A
- GWAV N/A
- EPS
- IMNN N/A
- GWAV N/A
- Revenue
- IMNN N/A
- GWAV $33,315,859.00
- Revenue This Year
- IMNN N/A
- GWAV N/A
- Revenue Next Year
- IMNN N/A
- GWAV N/A
- P/E Ratio
- IMNN N/A
- GWAV N/A
- Revenue Growth
- IMNN N/A
- GWAV N/A
- 52 Week Low
- IMNN $4.83
- GWAV $0.07
- 52 Week High
- IMNN $41.22
- GWAV $1.09
- Technical
- Relative Strength Index (RSI)
- IMNN 40.89
- GWAV 18.72
- Support Level
- IMNN $6.17
- GWAV $0.18
- Resistance Level
- IMNN $7.21
- GWAV $0.19
- Average True Range (ATR)
- IMNN 0.51
- GWAV 0.02
- MACD
- IMNN 0.14
- GWAV -0.01
- Stochastic Oscillator
- IMNN 20.45
- GWAV 5.08
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About GWAV Greenwave Technology Solutions Inc.
Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.